Vectibix(R) In Combination With Chemotherapy Significantly Improves Progression-Free Survival In First-Line Metastatic Colorectal Cancer
Links shared publicly online about this topic.
- 1,723total visits
Vectibix(R) In Combination With Chemotherapy Significantly Improves Progression-Free Survival In First-Line Metastatic Colorectal Cancer
Amgen (Nasdaq: AMGN) announced detailed results from the Phase 3 '203' trial evaluating Vectibix(R) (panitumumab) administered in combination with FOLFOX (an oxaliplatin-based chemotherapy) as the
View full resource at medicalnewstoday.com
Tags: Cancer, Chemotherapy, Rectal Cancer, Colon Cancer, Colorectal Cancer Medication, Vectibix, Amgen
Most Recently Shared on September 25, 2009 at 12:54 pm By:
Vectibix(R) In Combination With Chemotherapy Significantly Improves Progression-Free Survival In First-Line Met.. http://bit.ly/12AhEO
Advertisement
